ONCORESPONSE Trademark

Trademark Overview

On Thursday, April 7, 2022, a trademark application was filed for ONCORESPONSE with the United States Patent and Trademark Office. The USPTO has given the ONCORESPONSE trademark a serial number of 97351041. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, October 28, 2024. This trademark is owned by OncoResponse, Inc.. The ONCORESPONSE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of tumors, cancers, and malignancies
oncoresponse

General Information

Serial Number97351041
Word MarkONCORESPONSE
Filing DateThursday, April 7, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, October 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of tumors, cancers, and malignancies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 12, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOncoResponse, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98104
Party NameOncoResponse, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98104

Trademark Events

Event DateEvent Description
Monday, April 11, 2022NEW APPLICATION ENTERED
Tuesday, April 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 25, 2023ASSIGNED TO EXAMINER
Friday, January 27, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, January 27, 2023EXAMINERS AMENDMENT E-MAILED
Friday, January 27, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 27, 2023EXAMINER'S AMENDMENT ENTERED
Friday, January 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023SOU EXTENSION 1 FILED
Tuesday, October 10, 2023SOU EXTENSION 1 GRANTED
Thursday, October 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 19, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 19, 2024SOU EXTENSION 2 FILED
Friday, April 19, 2024SOU EXTENSION 2 GRANTED
Saturday, April 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 28, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 28, 2024SOU EXTENSION 3 FILED
Monday, October 28, 2024SOU EXTENSION 3 GRANTED

Related Keywords

oncoresponse cancers malignancies tumors treatment preparations pharmaceutical